企業プロフィール
CalciMedica 株価・ニュース・カタリスト
- ティッカー:
- CALC
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.56 USD (-2.86%)
終値
最終更新: 2026年8月24日
12.6M USD
時価総額
株価変動の要因
As of Aug 24, 2026, CALC closed down 2.86% at $0.5564. No new same-company headline was identified in the current news window.
企業概要
事業概要
CalciMedica is a biotechnology company focused on calcium-channel biology and inflammatory disease. Its story centers on using a targeted mechanism to address severe immune-mediated conditions.
所在地とセクター分類
CalciMedica is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
ビジネスモデルの特徴
The company depends on clinical validation, translational confidence, and capital discipline while it advances a focused pipeline. Investors watch early data and safety.
バイオ業界での位置付け
CalciMedica occupies a niche inflammation pathway position within biotech. The stock is driven by whether its biology can create a real clinical signal.
今後のカタリスト
- CalciMedica’s catalysts are calcium-signaling inflammation programs and any clinical update that clarifies whether the company can still build a viable development story. The next step matters because the story remains early.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。